Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cardiol Therapeutics Inc (CRDL.TO)
Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis

Recruitment Accelerating and Full Patient Enrollment Anticipated to be Completed During Q3 2024, up to Six Months Ahead of Schedule Multi-Center, International, Double-blind, Placebo-controlled Trial...

CRDL : 0.9100 (-3.19%)
CRDL.TO : 1.26 (+0.80%)
Stocks in play: Cardiol Therapeutics Inc.

Announced that President and CEO, David Elsley will present a company overview which will be broadcast ...

CRDL.TO : 1.26 (+0.80%)
Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference

Toronto, Ontario--(Newsfile Corp. - August 9, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL.TO : 1.26 (+0.80%)
CRDL : 0.9100 (-3.19%)
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market

Oakville, Ontario--(Newsfile Corp. - August 8, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 1.26 (+0.80%)
CRDL : 0.9100 (-3.19%)
Cardiol Therapeutics Reports Results of 2023 Annual General Meeting

Oakville, Ontario--(Newsfile Corp. - June 29, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL.TO : 1.26 (+0.80%)
CRDL : 0.9100 (-3.19%)
Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx™ in patients with recurrent pericarditis - a debilitating heart...

CRDL.TO : 1.26 (+0.80%)
CRDL : 0.9100 (-3.19%)
Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure

Results Demonstrate Cannabidiol Improved Cardiac Function, Reduced its Inflammatory State, and Prevented the Development of Hypertrophy and Fibrosis in Heart TissueData Presented at The American College...

CRDL.TO : 1.26 (+0.80%)
CRDL : 0.9100 (-3.19%)
Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent Pericarditis

The Cleveland Clinic Recruits First Participant in the Multi-center U.S. StudyOakville, Ontario--(Newsfile Corp. - January 17, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or...

CRDL.TO : 1.26 (+0.80%)
CRDL : 0.9100 (-3.19%)
Stocks in play: Cardiol Therapeutics Inc

Announces the initiation of a Phase II open-label pilot study (NCT05494788), to investigate the tolerance, ...

CRDL.TO : 1.26 (+0.80%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...

CRDL : 0.9100 (-3.19%)
CRDL.TO : 1.26 (+0.80%)
JNJ : 160.50 (-0.72%)
TAK : 15.84 (-0.56%)
NVO : 91.30 (+0.01%)
BMY : 58.90 (-0.30%)

Barchart Exclusives

The UAW Strike Could Get Nasty: Use Friday’s Unusual Options Activity to Profit
The UAW strike spread to 5,600 more workers on Friday as they walked off the job at 38 General Motors and Stellantis parts distribution centers in 20 states. In midday trading, investors are taking it all in stride. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar